Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fouque

Showing results (611-620 of 656) with videos related to

Pageof 66
Sort By:
Journal of Cellular Physiology|January 21, 2026
Blocking Sphingosine 1-phosphate Metabolism With Fingolimod Prevents the Progression of Vascular Smooth Muscle Cells Calcification in Chronic Kidney DiseaseNajwa Skafi, Solenne Pelletier, Christophe O Soulage, et al.
Kidney International Reports|August 15, 2025
Association of Phenylacetylglutamine and Cognitive Impairment in CKDHélène Levassort, Julie Boucquemont, Sophie Liabeuf, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 11, 2023
Kidney Function Decline and Serious Adverse Drug Reactions in Patients With CKDSolène M Laville, Valérie Gras-Champel, Aghilès Hamroun, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 26, 2016
Serum sclerostin: relation with mortality and impact of hemodiafiltrationLotte Lips, Camiel L M de Roij van Zuijdewijn, Piet M Ter Wee, et al.
Lancet (London, England)|November 5, 2015
The double challenge of resistant hypertension and chronic kidney diseasePatrick Rossignol, Ziad A Massy, Michel Azizi, et al.
Kidney International|December 21, 2007
A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney diseaseD Fouque, K Kalantar-Zadeh, J Kopple, et al.
Clinical Nutrition ESPEN|February 15, 2026
Anti-inflammatory effects and safety of omega-3 fatty acids in haemodialysis: a systematic review and meta-analysisCarolyn Blair, Adrian Slee, Clare McKeaveney, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|December 19, 2017
Eating During Hemodialysis Treatment: A Consensus Statement From the International Society of Renal Nutrition and MetabolismBrandon M Kistler, Debbie Benner, Jerrilynn D Burrowes, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 24, 2023
Cognitive performance is associated with glomerular filtration rate in patients with chronic kidney disease: results from the CKD-REIN cohortMarion Pépin, Hélène Levassort, Julie Boucquemont, et al.
Clinical Kidney Journal|July 5, 2021
Real-world safety and effectiveness of sucroferric oxyhydroxide for treatment of hyperphosphataemia in dialysis patients: a prospective observational studyMarc G Vervloet, Ioannis N Boletis, Angel L M de Francisco, et al.
Pageof 66

Showing results (611-620 of 656) with videos related to

Sort By:
Pageof 66
Journal of Cellular Physiology|January 21, 2026
Blocking Sphingosine 1-phosphate Metabolism With Fingolimod Prevents the Progression of Vascular Smooth Muscle Cells Calcification in Chronic Kidney DiseaseNajwa Skafi, Solenne Pelletier, Christophe O Soulage, et al.
Kidney International Reports|August 15, 2025
Association of Phenylacetylglutamine and Cognitive Impairment in CKDHélène Levassort, Julie Boucquemont, Sophie Liabeuf, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 11, 2023
Kidney Function Decline and Serious Adverse Drug Reactions in Patients With CKDSolène M Laville, Valérie Gras-Champel, Aghilès Hamroun, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 26, 2016
Serum sclerostin: relation with mortality and impact of hemodiafiltrationLotte Lips, Camiel L M de Roij van Zuijdewijn, Piet M Ter Wee, et al.
Lancet (London, England)|November 5, 2015
The double challenge of resistant hypertension and chronic kidney diseasePatrick Rossignol, Ziad A Massy, Michel Azizi, et al.
Kidney International|December 21, 2007
A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney diseaseD Fouque, K Kalantar-Zadeh, J Kopple, et al.
Clinical Nutrition ESPEN|February 15, 2026
Anti-inflammatory effects and safety of omega-3 fatty acids in haemodialysis: a systematic review and meta-analysisCarolyn Blair, Adrian Slee, Clare McKeaveney, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|December 19, 2017
Eating During Hemodialysis Treatment: A Consensus Statement From the International Society of Renal Nutrition and MetabolismBrandon M Kistler, Debbie Benner, Jerrilynn D Burrowes, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 24, 2023
Cognitive performance is associated with glomerular filtration rate in patients with chronic kidney disease: results from the CKD-REIN cohortMarion Pépin, Hélène Levassort, Julie Boucquemont, et al.
Clinical Kidney Journal|July 5, 2021
Real-world safety and effectiveness of sucroferric oxyhydroxide for treatment of hyperphosphataemia in dialysis patients: a prospective observational studyMarc G Vervloet, Ioannis N Boletis, Angel L M de Francisco, et al.
Pageof 66